StHealth Private Equity Medtech Fund. Alternative Investment BDC.

StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with both yield...

Former Tesla Foundation Vice Chairman Joins StHealth BDC.

St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board of directors. Dr....

Hercules BDC (HTGC) $13, to Present at FB Riley.

Hercules Capital to Discuss 2019 Growth Opportunities at the B. Riley FBR Institutional Investor Conference PALO ALTO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the...

Innovus (INNV) in Silicon Review Interview.

POISED FOR INNOVATION. The Silicon Review is the world’s most trusted online and print community for business & technology professionals. Our community members include thought-provoking...
internet stock review

Innovus (INNV) Conference Call Transcript.

Q1 2019 Results, 5/15/19.  Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM ET Company Participants Bassam Damaj - President and CEO Ryan...
biotech stock review, fluticare

Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)

(Originally published 4/25/2018) “I am very steady. I like to work slowly, but surely, to get to my goal.” Thus speaks Bassam Damaj, president and...
internet stock review, beyonce, uber

Beyonce Tells Uber “Pay me in Stock!”

We all know Beyoncé is brilliant, but this move she made in 2015 may be the absolute ultimate in future planning. Four years ago, Beyoncé...
biotech stock review, innovus

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup. We're adding...
candida auris, citius pharma, biotech stock review

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided...
Regoxidine, biotech stock review

Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.

Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women. Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or...

Latest article

GeoVax (GOVX) Conference Call and Transcript.

Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah. Guess what we'll choose to do? For the life...

Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.

Top Ranked Defense, Government and Enterprise Contractor Trying to Break Over $0.06. We are still sitting on the edge of our seat waiting for contract news,...

Broker Dealer – AtlasClear (ATCH) Conference Call

"AtlasClear is being built as an integrated financial services platform that will bring capital markets origination, clearing, and banking together under a single architecture."...